Amino-functionalized poly(l-lactide) lamellar single crystals as a valuable substrate for delivery of HPV16-E7 tumor antigen in vaccine development

References

• BritoLAO’HaganDTDesigning and building the next generation of improved vaccine adjuvantsJ Control Release201456357924998942
   PubMed Web of Science ®Google Scholar
• BolhassaniAJavanzadSSalehTHashemiMAghasadeghiMRSadatSMPolymeric nanoparticles: potent vectors for vaccine delivery targeting cancer and infectious diseasesHum Vaccin Immunother20141032133224128651
   PubMed Web of Science ®Google Scholar
• AhmedKKGearySMSalemAKApplying biodegradable particles to enhance cancer vaccine efficacyImmunol Res20145922022824838147
   PubMed Web of Science ®Google Scholar
• SinghMKazzazJUgozzoliMMalyalaPCheskoJO’HaganDTPolylactide-co-glycolide microparticles with surface adsorbed antigens as vaccine delivery systemsCurr Drug Deliv2006311512016472100
   PubMedGoogle Scholar
• OyewumiMOKumarACuiZNano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responsesExpert Rev Vaccines201091095110720822351
   PubMed Web of Science ®Google Scholar
• FogeCBrodinBFrokjaerSSundbladAParticle size and surface charge affect particle uptake by human dendritic cells in an in vitro modelInt J Pharm200529831532215961266
   PubMedGoogle Scholar
• AgarwalRRoyKIntracellular delivery of polymeric nanocarriers: a matter of size, shape, charge, elasticity and surface compositionTher Deliv2013470572323738668
   PubMedGoogle Scholar
• FifisTGamvrellisACrimeen-IrwinBSize-dependent immuno-genicity: therapeutic and protective properties of nano-vaccines against tumorsJ Immunol20041733148315415322175
   PubMed Web of Science ®Google Scholar
• HamdySHaddadiAHungRWLavasanifarATargeting dendritic cells with nano-particulate PLGA cancer vaccine formulationsAdv Drug Deliv Rev20116394395521679733
   PubMed Web of Science ®Google Scholar
• Jabbal-GillILinWJenkinsPPotential of polymeric lamellar substrate particles (PLSP) as adjuvants for vaccinesVaccine19991823825010506648
   PubMed Web of Science ®Google Scholar
• Zur HausenHPapillomavirus infections: a major cause of human cancerZur HausenHInfections Causing Human CancerWeinheim, GermanyWiley-VCH Verlag GmbH & Co KGaA2006145243
   Google Scholar
• FormanDde MartelCLaceyCJGlobal burden of human papil-lomavirus and related diseasesVaccine201230Suppl 5F12F2323199955
   PubMed Web of Science ®Google Scholar
• De SanjoseSQuintWGAlemanyLHuman papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Retrospective international survey and HPV time trends study groupLancet Oncol2010111048105620952254
   PubMed Web of Science ®Google Scholar
• SyrjänenSThe role of human papillomavirus infection in head and neck cancersAnn Oncol201021Suppl 7vii243vii24520943622
   PubMedGoogle Scholar
• MarianiLVenutiAHPV vaccine: an overview of immune response, clinical protection, and new approaches for the futureJ Transl Med2010810520979636
   PubMed Web of Science ®Google Scholar
• MoodyCALaiminsLAHuman papillomavirus oncoproteins: pathways to transformationNat Rev Cancer20101055056020592731
   PubMed Web of Science ®Google Scholar
• SuJHWuAScotneyEImmunotherapy for cervical cancer: research status and clinical potentialBioDrugs20102410912920199126
   PubMed Web of Science ®Google Scholar
• van der BurgSHMeliefCJTherapeutic vaccination against human papilloma virus induced malignanciesCurr Opin Immunol20112325225721237632
   PubMed Web of Science ®Google Scholar
• D’IlarioLFrancoliniIMartinelliAPiozziADipyridamole-loaded poly(L-lactide) single crystals as drug delivery systemsMacromol Rapid Commun20072819001904
   Web of Science ®Google Scholar
• PetroneLAmmendoliaMGCesoliniARecombinant HPV16 E7 assembled into particles induces an immune response and specific tumor protection administered without adjuvant in an animal modelJ Transl Med20119697721592382
   PubMed Web of Science ®Google Scholar
• LinKYGuarnieriFGStaveley-O’CarrollKFTreatment of established tumors with a novel vaccine that enhances major histo-compatibility class II presentation of tumor antigenCancer Res19965621268548765
   PubMed Web of Science ®Google Scholar
• IwataTDoiYMorphology and enzymatic degradation of poly(L-lactic acid) single crystalsMacromolecules19983124612467
   Web of Science ®Google Scholar
• CuiWLiXXieCZhuangHZhouSWengJHydroxyapatite nucleation and growth mechanism on electrospun fibers functionalized with different chemical groups and their combinationsBiomaterials2010314620462920303582
   PubMed Web of Science ®Google Scholar
• Di BonitoPGrassoFManginoGImmunomodulatory activity of a plant extract containing human papillomavirus 16-E7 protein in human monocyte-derived dendritic cellsInt J Immunopathol Pharmacol20092296797820074460
   PubMed Web of Science ®Google Scholar
• Di BonitoPGrassoFMochiSSerum antibody response to human papillomavirus (HPV) infections detected by a novel ELISA technique based on denatured recombinant HPV16 L1, L2, E4, E6 and E7 proteinsInfect Agent Cancer20061617150135
   PubMedGoogle Scholar
• CasiniGPetroneLBakryAFunctionalized poly(L-lactide) single crystals coated with antigens in development of vaccines. 2010 CRS Annual MeetingJ Control Release2010148e10621529579
   PubMed Web of Science ®Google Scholar
• Di BonitoPGrassoFMochiSAnti-tumor CD8+ T cell immunity elicited by HIV-1-based virus-like particles incorporating HPV-16 E7 proteinVirology2009395455519800648
   PubMed Web of Science ®Google Scholar
• FujitaMDoiYAnnealing and melting behavior of poly(L-lactic acid) single crystals as revealed by in situ atomic force microscopyBiomacromolecules200341301130712959598
   PubMed Web of Science ®Google Scholar
• CrollTIO’ConnorAJStevensGWCooper-WhiteJJControllable surface modification of poly(lactic-co-glycolic acid) (PLGA) by hydrolysis or aminolysis I: physical, chemical, and theoretical aspectsBiomacromolecules2004546347315003007
   PubMed Web of Science ®Google Scholar
• ZhuYGaoCLiuXShenJImmobilization of biomacromolecules onto aminolyzed poly(L-lactic acid) toward acceleration of endothelium regenerationTissue Eng200410536115009930
   PubMedGoogle Scholar
• FischerEWSterzelHJWegnerGKInvestigation of the structure of solution grown crystals of lactide copolymers by means of chemical reactionKolloid ZZ Polym1973251980990
   Web of Science ®Google Scholar
• ParkACimaLGIn vitro cell response to differences in poly-L-lactide crystallinityJ Biomed Mater Res1996311171308731156
   PubMed Web of Science ®Google Scholar
• BakryAMartinelliMBizzarriAA new approach for the preparation of hydrophilic poly(L-lactide) porous scaffold for tissue engineering by using lamellar single crystalsPolym Int20126111771185
   Web of Science ®Google Scholar
• ElsaesserAHowardCVToxicology of nanoparticlesAdv Drug Deliv Rev20126412913721925220
   PubMed Web of Science ®Google Scholar
• CattaneoAGGornatiRSabbioniENanotechnology and human health: risks and benefitsJ Appl Toxicol20103073074421117037
   PubMed Web of Science ®Google Scholar
• PalmMDGoldmanMPPatient satisfaction and duration of effect with PLLA: a review of the literatureJ Drugs Dermatol20098Suppl 10S15S2019891117
   PubMed Web of Science ®Google Scholar
• CoombesAGLavelleECDavisSSBiodegradable lamellar particles of poly(lactide) induce sustained immune responses to a single dose of adsorbed proteinVaccine1999172410242210392623
   PubMed Web of Science ®Google Scholar
• PepponiIStylianouEvan DolleweerdCImmune-complex mimics as a molecular platform for adjuvant-free vaccine deliveryPLoS One20138e6085523637771
   PubMed Web of Science ®Google Scholar